1,3-dipropyl-8-cyclopentylxanthine has been researched along with Apnea in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylxanthines like caffeine and theophylline have long been used to treat apnea of prematurity." | 3.80 | Methylxanthine reversal of opioid-induced respiratory depression in the neonatal rat: mechanism and location of action. ( Ballanyi, K; Ciechanski, P; Mosca, EV; Roy, A; Scheibli, EC; Wilson, RJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mosca, EV | 1 |
| Ciechanski, P | 1 |
| Roy, A | 1 |
| Scheibli, EC | 1 |
| Ballanyi, K | 1 |
| Wilson, RJ | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Apnea
| Article | Year |
|---|---|
Methylxanthine reversal of opioid-induced respiratory depression in the neonatal rat: mechanism and location of action.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Animals, Newborn; Apn | 2014 |